The short answer
If a standard yeast treatment does not help, that result alone cannot establish drug resistance. A clinician may use culture or other testing to identify the organism and guide treatment. Failed self-treatment can reflect the wrong diagnosis, irritation from the product, incomplete response, non-albicans Candida, resistance, or another process entirely. 1 2
Species identification answers a different question from symptoms
CDC recommends vaginal culture or PCR in complicated VVC to confirm the diagnosis and identify non-albicans Candida. 1 That matters because species cannot be reliably inferred from how the discharge looks, how intense the itch feels, or whether a familiar product seemed to help.
Candida glabrata is a specific example: CDC notes that it does not form the same pseudohyphae or hyphae and can therefore be harder to recognize on microscopy. 1 Culture or another validated identification method can add information that symptoms cannot.
A positive culture still needs clinical context
Candida can be detected without being the cause of symptoms. CDC's candidiasis testing page explicitly notes that a positive fungal culture does not always mean Candida is causing the current symptoms. 2 The VVC guideline similarly warns against treating culture detection without compatible signs or symptoms. 1
That distinction matters especially when testing is repeated: “detected again” and “causing this episode” are not identical statements.
What susceptibility testing can show
CDC notes increasing azole resistance among C. albicans vaginal isolates and says susceptibility testing can be considered for selected symptomatic patients who remain culture-positive despite therapy. 1 That recommendation applies only in a specific clinical situation. It does not mean every treatment failure proves resistance, and it does not mean susceptibility testing should be ordered or interpreted as a consumer self-test.
For the broader recurrent diagnostic process, see recurrent VVC testing. If the immediate question is why symptoms remain after an OTC course, see itching after OTC yeast treatment.
How treatment is selected
Boric acid, compounded treatment, suppressive schedules, and drug selection depend on the confirmed diagnosis, species, susceptibility data when relevant, prior treatment, pregnancy, and other clinical factors.
What should you take away?
Non-albicans Candida and antifungal resistance are questions for species identification, culture/PCR and selected susceptibility testing, not conclusions drawn from symptoms or failed OTC therapy. A laboratory result can narrow the problem, but it still has to be connected to the current symptoms and clinical context.
What are the limits of this information?
For a personal diagnosis or treatment decision, discuss your symptoms and health history with a healthcare professional, who may also recommend an examination or testing. See the medical information disclaimer.
Sources
- CDC: Vulvovaginal Candidiasis. Evidence reviewed 2026-09-14. Complicated VVC culture/PCR, non-albicans species, C. glabrata microscopy limitations, and susceptibility-testing context.
- CDC: Testing and Diagnosis for Candidiasis. Evidence reviewed 2026-09-14. Vaginal candidiasis testing and the fact that a positive fungal culture does not always mean Candida is causing symptoms.